LONDON, May 3, 2018 /PRNewswire/ --
Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America,
(Logo: Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
The generic drugs market is estimated at $257.3bn in 2017 and is expected to grow at a CAGR of 7.9% from 2017 to 2028. The generic drugs market is expected to grow at a CAGR of 7.2% in the second half of the forecast period.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 254-page report you will receive 66 tables and 84 figures- all unavailable elsewhere.
The 254-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
• Generic Drugs Market forecasts from 2018-2028
• Generic Drugs Regional Market and National Market forecasts from 2018-2028, covering: • North America: US & Canada • Europe: Germany, UK, France, Italy, Spain, Rest of Europe • Asia-Pacific: Japan, Australia, India, China, South Korea, Rest of Asia-Pacific • Middle East & Africa: South Africa, Saudi Arabia, U.A.E, Rest of Middle East & Africa • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
• SWOT Analysis and Porter's Five Forces Analysis of the generic drugs market.
• Assessment of selected leading companies that hold major market shares in the generic drugs market. • Teva • Novartis (Sandoz) • Allergan • Mylan • Pfizer • Abbott • Sun Pharma • Aspen • Fresenius Kabi • Sanofi • Dr. Reddy's Laboratories • Apotex
Visiongain's study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.
Buy our report today Generic Drugs Market Forecast 2018-2028: Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico.
To request a report overview of this report please email Sara Peerun at email@example.com or call Tel: +44-(0)-20-7336-6100
Or click on: https://www.visiongain.com/Report/2179/Generic-Drugs-Market-Forecast-2018-2028
List of Companies Mentioned in the Report
Arrow Group (Actavis)
Ascent Pharmahealth (Actavis)
Bioniche Pharma (Mylan)
BMP Sunstone (Sanofi)
CFR Pharmaceuticals (Abbott)
Dabur Pharma (Fresenius Kabi)
Dr Reddy's Laboratory
Ebewe Pharma (Novartis)
Eden Biopharm Group
Elder Pharmaceuticals (Torrent Pharmaceuticals)
EMS Sigma Pharma
Fenwal (Fresenius Kabi)
Forest Laboratories (Actavis)
Foshan Chanbende Development
Fougera Pharmaceuticals (Novartis)
Fresenius SE & Co
Genfar S.A (Sanofi)
IDEV Technologies (Abbott)
Imperial Credit Private Limited
Javelin Pharmaceuticals (Hospira)
Johnson & Johnson
Labesfal Genéricos (Fresenius Kabi)
Laboratorio Sanderson (Fresenius Kabi)
Laboratorios Kendrick (Sanofi)
Mayne Pharma (Hospira)
MN Pharma (Amgen)
Orchid Chemicals & Pharmaceuticals
Oriel Therapeutics (Novartis)
Parenteral Drugs India Ltd
Piramal (Abbott Laboratories)
PT Soho Global Health
Ranbaxy (Sun Pharmaceuticals)
Schein Pharmaceutical (Actavis)
Sigma Pharmaceuticals (Aspen)
Solvay Pharmaceuticals (Abbott)
Specifar Pharmaceuticals (Actavis)
St. Jude Medical
Teuto Brasileiro (Pfizer)
The Laboratory of Analytical Services International Ltd
Uteron Pharma (Actavis)
Warner Chilcott (Actavis)
Zhejiang Chiral Medicine Chemicals Co. Ltd
Zhejiang Hisun Pharmaceutical
To see a report overview please email Sara Peerun on firstname.lastname@example.org
Subscribe to our Free Newsletters!
A lump in the armpit can be due to a benign infection, allergy or fatty tissue growth. It is ...
Fennel seeds are a must-have in almost every Indian kitchen due to its health quotient. Here are a ...
True vertigo is a severe form of dizziness that is a movement hallucination. Try out some of these ...View All